Ruhong Jiang

Ruhong Jiang is an accomplished professional with a strong background in genetics, biology, and zoology. He holds a Doctor of Philosophy in Genetics from Oklahoma State University, a Master of Science in Biology from China Agricultural University, and a Bachelor of Science in Zoology from Fudan University. Additionally, he attended Taiyuan No. 1 Railway High School.

Throughout his career, Ruhong Jiang has held key positions in various prestigious organizations. He currently serves as the Chief Executive Officer at Asc Therapeutics. Previously, he co-founded and was the Chief Executive Officer of Applied Stemcell, Inc., and held the role of General Manager for China Operations at Micurx Pharmaceuticals, Inc. He also held director positions at esteemed institutions such as the Stanford Research Institute and Biomarker Pharmaceuticals. His expertise extends to pharmacogenomics, bioinformatics, and molecular diagnostics.

Furthermore, Ruhong Jiang has contributed his knowledge and skills to renowned companies including Boehringer Ingelheim and Genaissance Pharmaceuticals where he served as a Consultant in Pharmacogenomics and as a Senior Scientist and Project Manager in Pharmacogenomics and Bioinformatics, respectively.